GRI Bio, Inc.

GRI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$8,207-$13,037-$3,217-$9,303
Dep. & Amort.$4$57$50$73
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$448$1,680$1,515$563
Other Non-Cash$40$2,160$567$355
Operating Cash Flow-$8,611-$9,140-$1,085-$8,312
Investing Activities
PP&E Inv.-$396-$8-$3$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$3,842
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$396$0$0$0
Investing Cash Flow$0-$8-$3-$3,842
Financing Activities
Debt Repay.$0$1,250$1,237$244
Stock Issued$13,103$11,745-$111$100
Stock Repurch.-$1$0-$124$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1,271-$2,048$5$0
Financing Cash Flow$11,831$10,947$1,007$15,747
Forex Effect$0$0$0$0
Net Chg. in Cash$3,220$1,799-$81$0
Supplemental Information
Beg. Cash$1,808$9$90$337
End Cash$5,028$1,808$9$90
Free Cash Flow-$8,611-$9,148-$1,088-$8,312
GRI Bio, Inc. (GRI) Financial Statements & Key Stats | AlphaPilot